SLC7A11 and breast cancer: For example, miR-5096 enhances intracellular ROS, OH-, lipid ROS, and iron accumulation levels in breast cancer cells by targeting SLC7A11/xCT, reducing GSH and mitochondrial membrane potential, inducing ferroptosis in breast cancer cells, and further inhibiting their proliferation, migration, and invasion abilities (14).